Allworth Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Allworth Financial's CPRX Position: Q3 2026 in Review
Allworth Financial sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 1,781 shares — an estimated $56K sold.
Allworth Financial first reported a position in CPRX in Q3 2022 and held it in 14 quarters. The position peaked at $667K in Q4 2025. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Allworth Financial reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Allworth Financial sold 1,781 Catalyst Pharmaceutical shares in Q3 2026, an estimated $56K.
- Allworth Financial first reported a position in Catalyst Pharmaceutical in Q3 2022 and held it in 14 quarters.
- Allworth Financial's Catalyst Pharmaceutical position peaked at $667K in Q4 2025.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.